Navigation Links
Beckman Coulter Investor Events Second Half of 2008
Date:9/10/2008

ORANGE COUNTY, Calif., Sept. 10 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical tests, announces upcoming company presentations and investor events. Please mark your calendars accordingly.
(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

-- Q3 2008 Earnings Release scheduled for Tuesday, October 28, 2008. Q3

conference call scheduled for 5:00 p.m. ET.

-- Clinical Lab Tour: Investor Event scheduled for Thursday,

September 25, 2008, in Indianapolis, Indiana. For more information,

contact Beckman Coulter's Investor Relations Department at

(714) 773-7620.

-- Beckman Coulter 2008 Annual Business Review. The executive management

of the company will host one event in New York City, New York, on

Tuesday, December 16, 2008:

-- There will be a live webcast of this event. It will be accessible

through Beckman Coulter's website.

-- The company will attend the following conference:

-- Oppenheimer 19th Annual Healthcare Conference -- Tuesday,

November 4, 2008, in New York City, New York.

-- Lazard Capital Markets Healthcare Conference -- Tuesday,

November 18, 2008, New York City, New York.

-- Piper Jaffray Conference -- Tuesday, December 2, 2008, New York

City, New York.

-- RBC Conference -- Thursday, December 11, 2008, New York City, New

York.

Please refer to the company's website at http://www.beckmancoulter.com for updates on specific details of date and time for the company presentations referenced above. To access this information from our site, select "go to IR" under Investor Relations and look for "What's Ahead".

Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represent more than 78% of the company's 2007 revenue of $2.76 billion. For more information, visit http://www.beckmancoulter.com.

Contact: Cynthia Skoglund, (714) 773-8213

Manager, Investor Relations


'/>"/>
SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Beckman Coulter to Present at the Morgan Stanley Healthcare Unplugged Conference
2. Beckman Coulter to Present at the Thomas Weisel Healthcare Conference 2008
3. Beckman Coulter Announces Second Quarter 2008 Results
4. Beckman Coulter Announces Second Quarter 2008 Earnings to be Released on Friday, July 25, 2008, Before Market Opens
5. Upcoming Beckman Coulter Investor Events Second Half of 2008
6. Beckman Coulter to Present at Upcoming Healthcare Conferences
7. Beckman Coulter Announces First Quarter 2008 Results
8. Beckman Coulter Acquires Rights to Hepatitis C Virus
9. Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share
10. The Immune Tolerance Institute Announces Collaboration with Beckman Coulter Establishing a Multiplatform Immunophenotyping/Immunogenotyping Laboratory
11. Beckman Coulter to Present at the 2008 Bear Stearns London Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... -- Biocom, the association representing the Southern California ... San Diego companies to Washington ... Advocacy Fly-In. Biocom Fly-In participants had the opportunity to meet ... Centers for Medicare and Medicaid Services (CMS), the National Institutes ... Susan Davis and Scott Peters to ...
(Date:2/12/2016)... , February 12, 2016 ... Efforts by Enabling Scientific Understanding of Complex Diseases ... Rare Diseases --> ... diagnostics in South Asia and a leading provider of ... contribute $10 million to the GenomeAsia 100K consortium ...
(Date:2/11/2016)... , Germany and ... QGEN ; Frankfurt Prime Standard: QIA) today ... Targeted RNA Panels for gene expression profiling, expanding QIAGEN,s ... (NGS). The panels enable researchers to select from over ... changes and discover interactions between genes, cellular phenotypes and ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... dedicated to delivering cutting-edge information focused on the development and manufacture of ... become a premier sponsor of the 2016 BioProcess International Awards – Recognizing ...
Breaking Biology Technology:
(Date:2/3/2016)... 3, 2016 ... the "Emotion Detection and Recognition Market ... Others), Software Tools (Facial Expression, Voice Recognition ... Regions - Global forecast to 2020" ... http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has announced the addition ...
(Date:2/2/2016)... , Feb. 2, 2016 Checkpoint ... that Rising Market Are you interested in ... forecasts revenues for checkpoint inhibitors. Visiongain,s report gives ... submarket, product and national level. Avoid falling ... what progress, opportunities and revenues those emerging cancer ...
(Date:2/2/2016)... MOUNTAIN VIEW, Calif. , Feb. 2, 2016 ... diabetic retinopathy market, Frost & Sullivan recognizes US-based ... North America Frost & Sullivan Award for New ... technology provider in North America ... standard in the rapidly growing diabetic retinopathy market. ...
Breaking Biology News(10 mins):